Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 6119-47-7 | Product Number: Q0030
Quinine Hydrochloride Dihydrate

Purity: >98.0%(T)
Synonyms:
Product Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
25G |
€50.00
|
3 | 1 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | Q0030 |
Purity / Analysis Method | >98.0%(T) |
Molecular Formula / Molecular Weight | C__2__0H__2__4N__2O__2·HCl·2H__2O = 396.91 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Condition to Avoid | Light Sensitive |
CAS RN | 6119-47-7 |
Reaxys Registry Number | 8370495 |
PubChem Substance ID | 87575563 |
Merck Index (14) | 8061 |
MDL Number | MFCD00078498 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 90.0 area% |
Purity(Nonaqueous Titration) | 98.0 to 105.0 % |
Specific rotation [a]20/D | -245 to -255 deg(C=2, 0.1mol/l HCl(calcd.on dried substance) |
Solubility in hot Water | almost transparency |
Drying loss | max. 10.0 % |
Properties (reference)
Melting Point | 160 °C |
Specific Rotation | -250° (C=2,0.1mol/L HCl) |
GHS
Pictogram |
![]() ![]() |
Signal Word | Danger |
Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
Precautionary Statements | P261 : Avoid breathing dust. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P284 : Wear respiratory protection. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. |
Related Laws:
RTECS# | VA7700000 |
Transport Information:
HS Number | 2939200000 |
Application
Efflux pump research
Quinine has been reported to inhibit efflux pump in methicillin-resistant Staphylococcus aureus (MRSA).1)
(The product is for research purpose only.)
(The product is for research purpose only.)
Reference
- 1) Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA)
- 1) Fatal Dose of Sulphate of Quinine
- 2) Antimalarial Drug Toxicity (a review)
- 3) Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications (a review)
- 4) Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria (a review)
- 5) Quinine hydrochloride (a review on the physical properties, synthesis, biosynthesis, metabolism and pharmacokinetics, indications and dosages, toxicity and methods of determination)
Application
Quinine: An Antimalarial Substance
Quinine is one of the alkaloids which is included in the bark of cinchona tree and has been researched since 19th century.1) It has an anti-malarial activity2-4) and is considered to inhibit heme polymerase of plasmodium and to indicate toxicity to plasmodium. (The product is for research purpose only)
References
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.